Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-07-28Motor Evoked Potentials as a Biomarker in Alemtuzumab Treated Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2021-07-28The Effect on Telerehabilitation on Fatigue and Sleep Quality in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-07-23Microbiome Benchmarking to Identify Perturbations in Multiple Sclerosis I
-
CLINICAL_TRIALS study record update · 2021-07-22The Effect of Self-Acupressure Application on Functional Composite and Quality of Life in Multiple Sclerosis Patients
-
CLINICAL_TRIALS study record update · 2021-07-22The Impact of a Planned 12-week Dosing Interruption of Natalizumab on Immune Cell Trafficking, Pharmacokinetic (PK)/Pharmacodynamic (PD) Parameters, and Multiple Sclerosis (MS) Disease Stability.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-07-22Evaluation of the Effect of the Physiotherapy on Mobility and Functional Disorders of the Musculoskeletal System in People With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-07-16Decoding the B Cell Response in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-07-15Effects of a User-centered Exergame Training on Motor and Cognitive Functions in Persons With Multiple Sclerosis: A Pilot Quasi-Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2021-07-15A Placebo-Controlled Multi-Center Phase IIa Dose Finding Study of Ublituximab, a Third-Generation Anti-CD20 Monoclonal Antibody, in Patients With Relapsing Forms of Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2021-07-13The Effect of High Tone Power Therapy on Fatigue and Functional Outcomes in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-07-07Clinical Isolated Spinal Cord Syndrome Was Identified as Multiple Sclerosis Associated Risk Factor Analysis
-
CLINICAL_TRIALS study record update · 2021-07-02A Single-Arm Feasibility Study of the Life-Style Exercise and Activity Package for People Living With Progressive Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-06-29Exercise in Persons With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-06-25Investigation of Hand Functions and Related Parameters in People With Multiple Sclerosis in the Very Early Stage.
-
CLINICAL_TRIALS study record update · 2021-06-23Multiple Sclerosis and Voiding Symptoms: How to Assess?
-
CLINICAL_TRIALS study record update · 2021-06-23A Randomised Controlled Trial of Cognitive Behavioural Therapy Based Self Help for Fatigue in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-06-21Use of the Functional Gait Assessment in Patients With Multiple Sclerosis: Examining Reliability Between Face-to-Face and Online Applications
-
CLINICAL_TRIALS study record update · 2021-06-18SF-QUALIVEEN Turkish Cultural Adaptation, Validity and Reliability Study
-
CLINICAL_TRIALS study record update · 2021-06-15Upper Limb Assessment in Multiple Sclerosis: The Minnesota Manual Dexterity Test As A Measure Of Hand Function
-
CLINICAL_TRIALS study record update · 2021-06-14French Adaptation of the CCST (California Card Sorting Task). Comparison of 3 Packages to CCST With Multiple Sclerosis (MS) Patients
-
CLINICAL_TRIALS study record update · 2021-06-11Multicenter, Randomized, Double-blind, Parallel-group, Active-controlled, Superiority Study to Compare the Efficacy and Safety of Ponesimod to Teriflunomide in Subjects With Relapsing Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-06-11Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Dose-finding Study to Evaluate the Efficacy, Safety, and Tolerability of Three Doses of ACT-128800, an Oral S1P1 Receptor Agonist, Administered for Twenty-four Weeks in Patients With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2021-06-10Evaluating the Feasibility of Pandemic Forward, Telehealth Based Home Based Infusions
-
CLINICAL_TRIALS study record update · 2021-06-08Investigation of EEG and TMS-based Biomarkers of Amyotrophic Lateral Sclerosis, Multiple Sclerosis and Frontotemporal Dementia
-
CLINICAL_TRIALS study record update · 2021-06-03Effects of Aerobic Exercise on Brain Health in People With Multiple Sclerosis